Variant report
Variant | esv3353866 |
---|---|
Chromosome Location | chr17:16710977-16713075 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:7)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:7 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BATF | chr17:16711019-16711268 | GM12878 | blood: | n/a | chr17:16711188-16711198 chr17:16711187-16711198 |
2 | BATF | chr17:16710949-16711369 | GM12878 | blood: | n/a | chr17:16711188-16711198 chr17:16711187-16711198 |
3 | IRF4 | chr17:16710910-16711331 | GM12878 | blood: | n/a | n/a |
4 | IRF4 | chr17:16710955-16711450 | GM12878 | blood: | n/a | n/a |
5 | PAX5 | chr17:16710882-16711316 | GM12878 | blood: | n/a | n/a |
6 | POU2F2 | chr17:16710946-16711361 | GM12878 | blood: | n/a | n/a |
7 | SRF | chr17:16711001-16711242 | GM12878 | blood: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000264892 | TF binding region |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs577495009 | chr17:16711068-16711069 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs545466055 | chr17:16711076-16711077 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs145818769 | chr17:16711122-16711123 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs565567070 | chr17:16711131-16711132 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs528071278 | chr17:16711168-16711169 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs111755303 | chr17:16711215-16711216 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs572970685 | chr17:16711247-16711248 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs111694558 | chr17:16711305-16711306 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs541948361 | chr17:16711328-16711329 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs561823105 | chr17:16711363-16711364 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs183259384 | chr17:16711374-16711375 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs542101236 | chr17:16711378-16711379 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs530633350 | chr17:16711392-16711393 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs544464490 | chr17:16711423-16711424 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs564201660 | chr17:16711436-16711437 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs3869512 | chr17:16711477-16711478 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs188140519 | chr17:16711478-16711479 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs552141101 | chr17:16711488-16711489 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs557303980 | chr17:16711539-16711540 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs112231066 | chr17:16711542-16711543 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs113355537 | chr17:16711571-16711572 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs548293307 | chr17:16711573-16711574 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs568288655 | chr17:16711586-16711587 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs190967505 | chr17:16711666-16711667 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs141221135 | chr17:16711704-16711705 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs113735856 | chr17:16711712-16711713 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs182282888 | chr17:16711727-16711728 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs112269140 | chr17:16711734-16711735 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs540172877 | chr17:16711756-16711757 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs552956884 | chr17:16711774-16711775 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Wilms tumour | 21544195 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 16608533 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Chordoma | 21602918 | CNVD |
Miller-Dieker syndrome | 22283845 | CNVD |
Non-syndromic sensorineural hearing loss | 17457615 | CNVD |
Cancer | 22429812 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Breast cancer | 22028636 | CNVD |
Breast cancer | 20837533 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
colon cancer | 17210682 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Cancer | 16751803 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Chronic lymphocytic leukemia | 17971485 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Breast cancer | 16461572 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Breast cancer | 17133270 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Moyamoya disease | 22323933 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20724749 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
Acute myeloid leukemia | 17237825 | CNVD |
Colorectal cancer | 21645411 | CNVD |
HIV/AIDS | 22844521 | CNVD |
Psoriasis | 22844521 | CNVD |
Rheumatoid arthritis | 22844521 | CNVD |
Sclerosis systemic | 22844521 | CNVD |
Systemic lupus erythematosus | 22844521 | CNVD |
HIV/AIDS | 17953491 | CNVD |
HIV/AIDS | 20877625 | CNVD |
Immune disease | 21076436 | CNVD |
Rheumatoid arthritis | 17953491 | CNVD |
Type 1 diabetes | 17953491 | CNVD |
HIV/AIDS | 15637236 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Neurofibromatosis | 18196300 | CNVD |
Adenoid cystic carcinoma | 18332873 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Breast cancer | 17001317 | CNVD |
Rhabdomyosarcoma | 16790082 | CNVD |
Charcot-marie-tooth disease | 16463004 | CNVD |
Osteosarcoma | 22292074 | CNVD |
Breast cancer | 17603634 | CNVD |
Charcot | 16760730 | CNVD |
Mental retardation | 17901693 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
ovarian endometriomas | 16273235 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Gastric cancer | 18160780 | CNVD |
Smith-Magenis syndrome | 18923513 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16272173 | CNVD |
Austim spectrum disorder | 21302340 | CNVD |
Autism | 22492990 | CNVD |
Congenital abnormalities | 21549014 | CNVD |
Developmental delay | 18414209 | CNVD |
Developmental delay | 21549014 | CNVD |
Epilepsy | 20970697 | CNVD |
Mental retardation | 18414209 | CNVD |
Mental retardation | 21549014 | CNVD |
Smith-Magenis syndrome | 21981782 | CNVD |
Smith-Magenis syndrome | 20188345 | CNVD |
Smith-Magenis syndrome | 16775514 | CNVD |
Smith-Magenis syndrome | 22585170 | CNVD |
Smith-Magenis syndrome | 22241247 | CNVD |
Autism | 20970697 | CNVD |
Mental retardation | 19951919 | CNVD |
Potocki-Lupski syndrome | 21271655 | CNVD |
Potocki-lupski syndrome | 17357070 | CNVD |
Potocki-lupski syndrome | 20110824 | CNVD |
Potocki-lupski syndrome | 18923514 | CNVD |
Potocki-lupski syndrome | 22241247 | CNVD |
Potocki-lupski syndrome | 20188345 | CNVD |
Schizophrenia | 21399695 | CNVD |
Mental retardation | 16773131 | CNVD |
Adenocarcinoma | 19607727 | CNVD |
Squamous cell cancer | 19607727 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Charcot-marie-tooth disease | 22470819 | CNVD |
Neurofibromatosis | 22470819 | CNVD |
Neuropathy | 22470819 | CNVD |
Smith-Magenis syndrome | 18301319 | CNVD |
Smith-Magenis syndrome | 17357070 | CNVD |
Smith-Magenis syndrome | 18469339 | CNVD |
Smith-Magenis syndrome | 22241097 | CNVD |
Smith-Magenis syndrome | 22470819 | CNVD |
Tourette syndrome | 18923514 | CNVD |
Type 1 diabetes | 22470819 | CNVD |
Potocki-lupski syndrome | 18469339 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Neuropathy | 17597781 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 17015230 | CNVD |
Smith-Magenis syndrome | 17597781 | CNVD |
Potocki-lupski syndrome | 18059269 | CNVD |
Potocki-lupski syndrome | 17597781 | CNVD |
Mental retardation | 17847001 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Breast cancer | 20409316 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Breast cancer | 21509527 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr17:16689600-16711600 | Weak transcription | Skeletal Muscle Male | skeletal muscle |
2 | chr17:16698000-16711800 | Weak transcription | Primary mononuclear cells fromperipheralblood | Blood |
3 | chr17:16711600-16711800 | Enhancers | Skeletal Muscle Male | skeletal muscle |